Keyphrases
Glaucomatous
100%
Transforming Growth Factor-β
100%
Promoter Methylation
100%
Lamina Cribrosa Cells
100%
Global DNA Methylation
100%
Glaucoma
40%
Methylation
30%
DNA Methyltransferase 1 (DNMT1)
30%
Fibrosis
30%
Immunofluorescence
20%
DNA Methylation (DNAm)
20%
Quantitative Methylation-specific PCR (Q-MSP)
20%
Therapeutic Target
10%
Novel Therapeutics
10%
Optic Neuropathy
10%
Quantitative PCR
10%
Lamina Cribrosa
10%
Methyl-CpG-binding Protein 2 (MeCP2)
10%
α-smooth muscle Actin (α-SMA)
10%
Profibrotic Genes
10%
COL1A1
10%
Human Donor
10%
Methylation Status
10%
TGF-1
10%
Matrix Gene
10%
Collagen
10%
Neuroscience
Promoter Region
100%
Fibrinogen
100%
DNA Methylation
100%
Cancer Growth Factor
100%
Methylation
100%
Glaucoma
50%
Immunofluorescence
25%
DNA (Cytosine 5) Methyltransferase 1
25%
ELISA
12%
Optic Neuropathy
12%
Real-Time Polymerase Chain Reaction
12%
DNA Methyltransferase
12%
Methyl CpG Binding Protein 2
12%
Smooth Muscle Actin
12%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Methylation
100%
DNA Methylation
100%
Fibrinogen
100%
Cancer Growth Factor
100%
DNMT1
25%
Immunofluorescence
25%
Normal Human
12%
DNA Methyltransferase
12%
Real-Time Polymerase Chain Reaction
12%
Actin
12%
Enzyme
12%
Binding Protein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrinogen
100%
Cancer Growth Factor
100%
Glaucoma
50%
Fibrosis
37%
DNA (Cytosine 5) Methyltransferase 1
25%
Optic Nerve Disease
12%
Enzyme-Linked Immunosorbent Assay
12%
Normal Human
12%
Smooth Muscle Actin
12%
Methyl CpG Binding Protein 2
12%
DNA Methyltransferase
12%